318 related articles for article (PubMed ID: 14511258)
21. Asbestos fiber analysis in 27 malignant mesothelioma cases.
Murai Y; Kitagawa M
Am J Ind Med; 1992; 22(2):193-207. PubMed ID: 1415286
[TBL] [Abstract][Full Text] [Related]
22. Biomarker assessments in asbestos-exposed workers as indicators for selective prevention of mesothelioma or bronchogenic carcinoma: rationale and practical implementations.
Pluygers E; Baldewyns P; Minette P; Beauduin M; Gourdin P; Robinet P
Eur J Cancer Prev; 1991 Oct; 1(1):57-68. PubMed ID: 1842686
[TBL] [Abstract][Full Text] [Related]
23. Chronological trends in the causation of malignant mesothelioma: Fiber burden analysis of 619 cases over four decades.
Roggl VL; Green CL; Liu B; Carney JM; Glass CH; Pavlisko EN
Environ Res; 2023 Aug; 230():114530. PubMed ID: 36965800
[TBL] [Abstract][Full Text] [Related]
24. Asbestos-related benign disease and cancer: symptoms and treatment.
Gruber UF
Anticancer Drugs; 1990 Dec; 1(2):187-97. PubMed ID: 2151850
[TBL] [Abstract][Full Text] [Related]
25. Malignant mesotheliomas in Kure City, Japan: the relationship of asbestos exposure.
Kishimoto T; Sato T; Ono T; Okada K; Masuda Y; Ito H
Cancer Invest; 1989; 7(5):407-10. PubMed ID: 2620245
[TBL] [Abstract][Full Text] [Related]
26. Diffuse malignant pleural mesothelioma in an urban hospital: clinical spectrum and trend in incidence over time.
Shepherd KE; Oliver LC; Kazemi H
Am J Ind Med; 1989; 16(4):373-83. PubMed ID: 2610210
[TBL] [Abstract][Full Text] [Related]
27. Mortality rates from asbestos-related diseases in Italy during the first year of the COVID-19 pandemic.
Fazzo L; Grande E; Zona A; Minelli G; Crialesi R; Iavarone I; Grippo F
Front Public Health; 2023; 11():1243261. PubMed ID: 38292377
[TBL] [Abstract][Full Text] [Related]
28. Relative risk of mesothelioma associated with different levels of exposure to asbestos.
Tuomi T; Huuskonen MS; Virtamo M; Tossavainen A; Tammilehto L; Mattson K; Lahdensuo A; Mattila J; Karhunen P; Liippo K
Scand J Work Environ Health; 1991 Dec; 17(6):404-8. PubMed ID: 1788534
[TBL] [Abstract][Full Text] [Related]
29. Sudden death of an elderly man with multiple malignant neoplasms.
Boglioli LR; Taff ML; Spitz WU; Gordon RE
Am J Forensic Med Pathol; 1991 Sep; 12(3):265-71. PubMed ID: 1750402
[TBL] [Abstract][Full Text] [Related]
30. Pleural mesothelioma after neighborhood exposure to asbestos during childhood.
Inase N; Takayama S; Nakayama M; Miura H; Kimula Y
Jpn J Med; 1991; 30(4):343-5. PubMed ID: 1942646
[TBL] [Abstract][Full Text] [Related]
31. Malignant mesothelioma of the pleura in Trieste, Italy.
Giarelli L; Bianchi C; Grandi G
Am J Ind Med; 1992; 22(4):521-30. PubMed ID: 1442787
[TBL] [Abstract][Full Text] [Related]
32. Pleural mesothelioma.
Ruffie PA
Curr Opin Oncol; 1991 Apr; 3(2):328-34. PubMed ID: 2069994
[TBL] [Abstract][Full Text] [Related]
33. Study of asbestos bodies in Japanese urban patients.
Hiraoka K; Horie A; Kido M
Am J Ind Med; 1990; 18(5):547-54. PubMed ID: 2173890
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical Expression of Aquaporin-1 in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Report.
Angelico G; Caltabiano R; Loreto C; Ieni A; Tuccari G; Ledda C; Rapisarda V
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495596
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic criteria for human diffuse malignant mesothelioma.
Suzuki Y
Acta Pathol Jpn; 1992 Nov; 42(11):767-86. PubMed ID: 1281957
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients.
Kishimoto T; Fujimoto N; Ebara T; Omori T; Oguri T; Niimi A; Yokoyama T; Kato M; Usami I; Nishio M; Yoshikawa K; Tokuyama T; Tamura M; Yokoyama Y; Tsuboi K; Matsuo Y; Xu J; Takahashi S; Abdelgied M; Alexander WT; Alexander DB; Tsuda H
BMC Cancer; 2019 Dec; 19(1):1204. PubMed ID: 31823764
[TBL] [Abstract][Full Text] [Related]
37. Pleural mesotheliomas and asbestos exposure in the pulp and paper industries: a new risk group identified by linkage of official registers.
Järvholm B; Malker H; Malker B; Ericsson J; Sällsten G
Am J Ind Med; 1988; 13(5):561-7. PubMed ID: 3376945
[TBL] [Abstract][Full Text] [Related]
38. Biomarker assessments in asbestos-exposed workers as indicators for selective prevention of mesothelioma or bronchogenic carcinoma: rationale and practical implementations.
Pluygers E; Baldewyns P; Minette P; Beauduin M; Gourdin P; Robinet P
Eur J Cancer Prev; 1992 Feb; 1(2):129-38. PubMed ID: 1463974
[TBL] [Abstract][Full Text] [Related]
39. Comparative genomic hybridisation in malignant deciduoid mesothelioma.
Scattone A; Pennella A; Gentile M; Musti M; Nazzaro P; Buonadonna AL; Marzullo A; Cavone D; Pollice L; Serio G
J Clin Pathol; 2006 Jul; 59(7):764-9. PubMed ID: 16569690
[TBL] [Abstract][Full Text] [Related]
40. Pseudomesotheliomatous carcinoma of the lung with asbestos exposure.
Simonsen J
Am J Forensic Med Pathol; 1986 Mar; 7(1):49-51. PubMed ID: 2942032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
